Skip to Content

  • Search

View Additional Section Content

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 26-Week, Phase 3 Study of Two Doses of EVP-6124 or Placebo in Subjects with Mild to Moderate Alzheimer’s Disease Currently or Previously Receiving an Acetylcholinesterase Inhibitor Medication

For more information on this trial, click the link below.

https://clinicaltrials.gov/ct2/show/NCT01969123?term=nct01969123&rank=1

Clinical Trial Categories

  • Alzheimer's Disease
Contact
Jennifer McGowan at 215-327-0161

Location

  • Abington Neurological Associates, Ltd

Find a Physician
Search Our Directory

215-481-MEDI

Schedule a
Test

215-481-EXAM

Clinical Trials Details